Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
Kazuyuki Kumagai,1 Nobuchika Ogino,2 Marie Fukami,1 Mariko Furukawa1 1Kami-iida Daiichi General Hospital, Nagoya, Aichi, Japan; 2Shinjo Ophthalmologic Institute, Miyazaki, Japan Purpose: The purpose of this study was to determine the long-term outcomes of intravitreal bevacizumab (IVB) or intravit...
Guardado en:
Autores principales: | Kumagai K, Ogino N, Fukami M, Furukawa M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa88baaabfcc46a7aa88866c94c54a25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019) -
The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017) -
Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
por: Nishida A, et al.
Publicado: (2017) -
Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
por: Kartasasmita AS, et al.
Publicado: (2016) -
Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)